[1]
Stagno, F. et al. 2021. Long term follow-up of frontline Dasatinib in older patients with chronic myeloid leukemia in chronic phase treated outside clinical trials: a real-life cohort observational study. Acta Oncologica. 60, 11 (Nov. 2021), 1527–1533. DOI:https://doi.org/10.1080/0284186X.2021.1971292.